Skip to main content
. 2020 Jan 9;59(5):1828–1836. doi: 10.1002/anie.201912312

Figure 1.

Figure 1

Differences in the cellular environment (pH and metabolism) affect the dissolution kinetics of metal oxides, in this case CuO NPs. Hence, we postulate that a kinetic design on the particle side, through Fe‐doping, opens a therapeutic window for cancer treatment. This requires a release that is fast enough to target cancer cells, but significantly slowed down in normal cells such that regulatory mechanisms can handle the stress.